Related Experiment Video
Updated: May 5, 2026
04:30
Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
3.0K
Valvular aortic stenosis and coronary atherosclerosis: pathophysiology and clinical consequences
J Delaye1, P Chevalier, F Delahaye
1Service de Cardiologie, Hôpital Cardiologique Louis Pradel, Lyon, France.
European Heart Journal
|April 1, 1988
Summary
Valvular aortic stenosis (VAS) and coronary atherosclerosis impact heart function. Severe hypertrophy suggests VAS is the primary issue, while less severe cases benefit from combined treatments.
Area of Science:
- Cardiology
- Cardiovascular Pathophysiology
- Interventional Cardiology
Background:
- Valvular aortic stenosis (VAS) and coronary atherosclerosis frequently coexist, complicating cardiovascular assessment.
- Progressive aortic stenosis reduces valvular area, impairs coronary blood flow, and induces myocardial hypertrophy, worsening left ventricular function.
- Significant coronary artery stenosis causes a permanent reduction in coronary blood flow, exacerbated during exertion.
Purpose of the Study:
- To investigate the relationship between the severity of valvular aortic stenosis (VAS) and myocardial hypertrophy (MH) in patients with coexisting coronary artery disease.
- To differentiate therapeutic strategies based on the degree of myocardial hypertrophy in VAS patients with coronary atherosclerosis.
Main Methods:
- Utilized advanced investigative methods including electrocardiography (ECG), echocardiography, angiography, and histology.
- Assessed left ventricular mass to categorize myocardial hypertrophy severity (severe > 180 g m-2, less severe < 180 g m-2).
Main Results:
- In severe myocardial hypertrophy (LV mass > 180 g m-2), angina pectoris is predominantly linked to VAS, indicating aortic outflow obstruction removal as primary therapy.
- In less severe myocardial hypertrophy (LV mass < 180 g m-2), combined surgical treatment for valvular lesions and myocardial revascularization is indicated.
Conclusions:
- The degree of myocardial hypertrophy is a critical factor in determining the optimal treatment strategy for patients with concomitant valvular aortic stenosis and coronary artery disease.
- Tailoring interventions based on hypertrophy severity ensures appropriate management, prioritizing aortic stenosis relief or combined revascularization and valvular repair.
Related Concept Videos
01:22Mitral Stenosis I: Introduction
1.8K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
01:15Aortic Regurgitation I: Introduction
1.6K
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.6K
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
1.2K
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.2K
01:30Coronary Artery Disease I: Introduction
1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
01:26Coronary Artery Disease II: Pathophysiology
1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
954
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
954